Lumigan RC

Lumigan RC is an ophthalmic solution that reduces elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Formulated with bimatoprost 0.01%, it helps preserve vision by promoting better fluid drainage from the eye. Lumigan RC is a trusted treatment option for maintaining long-term eye health.

Benefits of Lumigan RC

• Effectively lowers intraocular pressure in glaucoma and ocular hypertension.
• Reduces the risk of optic nerve damage and vision loss.
• Easy-to-use once-daily application.
• Suitable for patients needing consistent and reliable eye pressure management.

Dosage:

• 0.01% in 5ml and 7.5ml
• Instill one drop in the affected eye(s) once daily, preferably in the evening.
• Avoid exceeding the recommended dosage to prevent reduced effectiveness.
• Follow your healthcare provider’s instructions for safe and effective use.

Warnings and Precautions:

• Lumigan RC may cause darkening of the iris, eyelid skin, or eyelashes over time. This change may be permanent.
• Monitor for possible side effects such as eye redness, dryness, or irritation.
• Remove contact lenses before application and wait at least 15 minutes before reinserting them.
• Use caution if you have a history of eye infections, uveitis, or other ocular conditions.
• Inform your doctor about any other medications or eye drops you are using.

Usage Instructions:

• Wash your hands before application to maintain eye hygiene.
• Tilt your head back, gently pull down the lower eyelid, and instill one drop in the affected eye(s).
• Avoid touching the tip of the bottle to any surface to prevent contamination.

Storage Information:

• Store Lumigan RC at room temperature, between 36°F and 77°F (2°C and 25°C).
• Keep the bottle tightly closed when not in use to protect it from contamination.
• Keep children out of reach and avoid exposure to direct sunlight.

Common Side Effects:

• Mild eye redness or discomfort.
• Increased eyelash growth or changes in eyelash appearance.
• Temporary blurred vision immediately after application.
• Rarely is the iris darkened or pigmentation changes in eyelids.

More information about Lumigan RC:

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide